These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21371765)

  • 1. Predictive value of serial assessment of endothelial function in chronic heart failure.
    Takishima I; Nakamura T; Hirano M; Kitta Y; Kobayashi T; Fujioka D; Saito Y; Watanabe K; Watanabe Y; Mishina H; Obata JE; Kawabata K; Tamaru S; Kugiyama K
    Int J Cardiol; 2012 Jul; 158(3):417-22. PubMed ID: 21371765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease.
    Kitta Y; Obata JE; Nakamura T; Hirano M; Kodama Y; Fujioka D; Saito Y; Kawabata K; Sano K; Kobayashi T; Yano T; Nakamura K; Kugiyama K
    J Am Coll Cardiol; 2009 Jan; 53(4):323-30. PubMed ID: 19161880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease.
    Shechter M; Issachar A; Marai I; Koren-Morag N; Freinark D; Shahar Y; Shechter A; Feinberg MS
    Int J Cardiol; 2009 May; 134(1):52-8. PubMed ID: 18479768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index.
    Brevetti G; Silvestro A; Schiano V; Chiariello M
    Circulation; 2003 Oct; 108(17):2093-8. PubMed ID: 14530195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incremental prognostic significance of peripheral endothelial dysfunction in patients with heart failure with normal left ventricular ejection fraction.
    Akiyama E; Sugiyama S; Matsuzawa Y; Konishi M; Suzuki H; Nozaki T; Ohba K; Matsubara J; Maeda H; Horibata Y; Sakamoto K; Sugamura K; Yamamuro M; Sumida H; Kaikita K; Iwashita S; Matsui K; Kimura K; Umemura S; Ogawa H
    J Am Coll Cardiol; 2012 Oct; 60(18):1778-86. PubMed ID: 23040568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
    Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ
    Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In patients with coronary artery disease endothelial function is associated with plasma levels of C-reactive protein and is improved by optimal medical therapy.
    Vitale C; Cerquetani E; Wajngarten M; Leonardo F; Silvestri A; Mercuro G; Fini M; Ramires JA; Rosano GM
    Ital Heart J; 2003 Sep; 4(9):627-32. PubMed ID: 14635381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined assessment of flow-mediated dilation of the brachial artery and brachial-ankle pulse wave velocity improves the prediction of future coronary events in patients with chronic coronary artery disease.
    Sugamata W; Nakamura T; Uematsu M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Obata JE; Watanabe Y; Watanabe K; Kugiyama K
    J Cardiol; 2014 Sep; 64(3):179-84. PubMed ID: 24556367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical correlates and prognostic value of flow mediated dilation in patients with non-ST segment elevation acute coronary syndromes.
    Careri G; Nerla R; Di Monaco A; Russo G; Stazi A; Villano A; Sestito A; Lanza GA; Crea F
    Am J Cardiol; 2013 Jan; 111(1):51-7. PubMed ID: 23062313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte growth factor is a strong predictor of mortality in patients with advanced heart failure.
    Rychli K; Richter B; Hohensinner PJ; Kariem Mahdy A; Neuhold S; Zorn G; Berger R; Mörtl D; Huber K; Pacher R; Wojta J; Niessner A; Hülsmann M
    Heart; 2011 Jul; 97(14):1158-63. PubMed ID: 21572126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral vascular endothelial function testing for the diagnosis of coronary artery disease.
    Jambrik Z; Venneri L; Varga A; Rigo F; Borges A; Picano E
    Am Heart J; 2004 Oct; 148(4):684-9. PubMed ID: 15459601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial function predicts mortality risk in patients with advanced ischaemic chronic heart failure.
    Shechter M; Matetzky S; Arad M; Feinberg MS; Freimark D
    Eur J Heart Fail; 2009 Jun; 11(6):588-93. PubMed ID: 19406838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulse pressure is a predictor of vascular endothelial function in middle-aged subjects with no apparent heart disease.
    Beigel R; Dvir D; Arbel Y; Shechter A; Feinberg MS; Shechter M
    Vasc Med; 2010 Aug; 15(4):299-305. PubMed ID: 20724375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactive hyperemia is associated with adverse clinical outcomes in heart failure.
    Paine NJ; Hinderliter AL; Blumenthal JA; Adams KF; Sueta CA; Chang PP; O'Connor CM; Sherwood A
    Am Heart J; 2016 Aug; 178():108-14. PubMed ID: 27502858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.
    Nishii M; Inomata T; Takehana H; Naruke T; Yanagisawa T; Moriguchi M; Takeda S; Izumi T
    J Am Coll Cardiol; 2008 Jun; 51(24):2329-35. PubMed ID: 18549918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial vasomotor dysfunction in the brachial artery is associated with late in-stent coronary restenosis.
    Kitta Y; Nakamura T; Kodama Y; Takano H; Umetani K; Fujioka D; Saito Y; Kawabata K; Obata JE; Ichigi Y; Mende A; Kugiyama K
    J Am Coll Cardiol; 2005 Aug; 46(4):648-55. PubMed ID: 16098430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term prognostic role of flow-mediated dilatation of the brachial artery after acute coronary syndromes without ST elevation.
    Karatzis EN; Ikonomidis I; Vamvakou GD; Papaioannou TG; Protogerou AD; Andreadou I; Voidonikola PT; Karatzi KN; Papamichael CM; Lekakis JP
    Am J Cardiol; 2006 Dec; 98(11):1424-8. PubMed ID: 17126643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death.
    Fischer D; Rossa S; Landmesser U; Spiekermann S; Engberding N; Hornig B; Drexler H
    Eur Heart J; 2005 Jan; 26(1):65-9. PubMed ID: 15615801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoprotegerin predicts progression of chronic heart failure: results from CORONA.
    Ueland T; Dahl CP; Kjekshus J; Hulthe J; Böhm M; Mach F; Goudev A; Lindberg M; Wikstrand J; Aukrust P; Gullestad L
    Circ Heart Fail; 2011 Mar; 4(2):145-52. PubMed ID: 21216833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effects after withdrawal of simvastatin on brachial artery endothelial function in patient with coronary heart disease or risk factors].
    Chen H; Ren JY; Wu B; Liu X; Wang RJ; Li LJ; Luo Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jun; 35(6):531-5. PubMed ID: 17711713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.